Rothschild Investment LLC Akero Therapeutics, Inc. Transaction History
Rothschild Investment LLC
- $1.49 Trillion
- Q1 2025
A detailed history of Rothschild Investment LLC transactions in Akero Therapeutics, Inc. stock. As of the latest transaction made, Rothschild Investment LLC holds 110 shares of AKRO stock, worth $4,941. This represents 0.0% of its overall portfolio holdings.
Number of Shares
110
Previous 90
22.22%
Holding current value
$4,941
Previous $2.5 Million
77.84%
% of portfolio
0.0%
Previous 0.0%
Shares
5 transactions
Others Institutions Holding AKRO
# of Institutions
225Shares Held
67.9MCall Options Held
321KPut Options Held
558K-
Rtw Investments, LP New York, NY6.86MShares$308 Million3.11% of portfolio
-
Janus Henderson Group PLC London, X06.03MShares$271 Million0.09% of portfolio
-
Black Rock Inc. New York, NY5.59MShares$251 Million0.0% of portfolio
-
General Atlantic LLC New York, NY5.23MShares$235 Million5.21% of portfolio
-
Price T Rowe Associates Inc Baltimore, MD4.32MShares$194 Million0.01% of portfolio
About Akero Therapeutics, Inc.
- Ticker AKRO
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 46,417,600
- Market Cap $2.09B
- Description
- Akero Therapeutics, Inc., a cardio-metabolic nonalcoholic steatohepatitis (NASH) company, engages in the development of medicines designed to restore metabolic balance and improve overall health. The company's lead product candidate is efruxifermin (EFX), an analog of fibroblast growth factor 21, which protects against cellular stress and regula...